Navigation Links
Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
Date:2/14/2008

Northfield Medimation offers FDA validation designed into advanced

automation processes

NORTHFIELD, Minn., Feb. 14 /PRNewswire/ -- Northfield Automation, a leader in roll-to-roll process equipment for thin-material handling applications, announces the formation of Northfield Medimation, a wholly owned subsidiary that will diversify the company into the medical device market. The subsidiary provides advanced automation and robotics for applications such as cardio-vascular devices and fabrication of transdermal patches, test strips and related diagnostic materials.

The company also announces the appointment of Jahn Stopperan as the subsidiary's general manager. Formerly principal of Technasport, a new product development company, Stopperan brings more than 20 years of experience in business management, marketing, sales, and product development to his new role at Northfield Medimation.

"The medical device industry is a stable market with many new opportunities for automation that can benefit by having FDA validation completed by the equipment provider," according to Brett Reese, chairman and chief executive officer of Northfield Automation. "In addition to medical, we are diversifying into the thin solar cell, electronic display and flexible battery industries to help us reach our growth goals of 25 percent per year," he says.

Customization, reliability and validation are Northfield Medimation's competitive advantages based on its design-intensive focus and engineering expertise of its parent company.

Customized automation solutions are engineered to meet complex medical manufacturing requirements for single machines or integrated systems. Many applications are automated to reduce process variability, limit risk and reduce manual content.

Complete validation services include documentation materials designed to meet each customer's specifications and regulatory requirements. By outsourcing the validation task, medical device manufacturers can save post-production time as well as improve consistency and quality. It also frees up engineering resources to focus on other production ramp-up areas. This customized service increases the customer's go-to-market confidence and guarantees equipment functionality.

Reliability of Northfield Medimation's processes and equipment is based on shared technical and manufacturing resources with its parent company. The company's market niche is middle-tier medical device manufacturers and divisions of larger med-tech companies, with needs ranging from small development projects to high-end, turnkey systems. Many of these customers may not have in-house validation capabilities.

Established in 2000, Northfield Automation Systems, Inc. designs, engineers and fabricates automation machinery for OEMs and high-volume, custom manufacturers. Its engineers provide consultative support for streamlined manufacturing processes with turnkey, integrated equipment. The company's vision is to become the global leader in web-based, high-precision, roll-to-roll processing of thin-film applications, including flexible electronics, display, solar, flexible battery, and organic electronics. Its wholly owned subsidiary, Northfield Medimation, focuses on advanced automation and robotics for the medical device industry. Both companies are located in Northfield, Minn., which is 35 minutes south of Minneapolis. For more information, visit http://www.northfieldautomation.com and http://www.northfieldmedimation.com.


'/>"/>
SOURCE Northfield Automation Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
2. IH Systems Announces $7.6 million in Financing to Advance RIVA Pharmacy Automation System
3. Axeda Selected for Remote Monitoring and Service of Automation Technologies
4. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
5. NBTY Announces Preliminary Unaudited Net Sales Results for January 2008
6. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
7. Vical Announces News Release and Conference Call Schedule for 2007 Financial Results
8. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
9. ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
10. NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
11. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed by ... globally recognized standard that establishes guidance for critical processes within translation, quality ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
(Date:1/23/2017)... January 23, 2017 Longer life expectancy and rising ... global market for medical device technologies. BCC Research reveals in ... Asia-Pacific region, should see strong growth due to rising ... incomes. Continue Reading ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: